Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 211–225 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4513 PRDM12 Gene HSAN8 Genetic Test This test analyzes the PRDM12 gene to detect mutations associated with Hereditary Sensory and Autonomic Neuropathy Type 8 (HSAN8). It identifies disease-causing variants in both co...	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the PRDM12 gene", "Exon and splice-site coverage of the PRDM12 gene"] Parameters [] Preparation ["Fasting is not required", "No specific medication or diet restrictions"] Indications ["Suspected diagnosis of HSAN8 based on clinical presentation", "Family history of HSAN8", "Genetic counseling for individuals with HSAN8 or family history"] Measurement technique Confirm with laboratory Codes LOINC: 94209-3 ICD-10: G60.8, G90.8 Clinical summary This test analyzes the PRDM12 gene to detect mutations associated with Hereditary Sensory and Autonomic Neuropathy Type 8 (HSAN8). It identifies disease-causing variants in both copies of the gene, confirming the diagnosis.
TEST-6099 PRF1 Gene Aplastic Anemia Genetic Test This diagnostic test evaluates the PRF1 gene for pathogenic variants associated with inherited bone marrow failure syndromes, including aplastic anemia and FHLH2.	Whole Blood (EDTA, 3–5 mL), Extracted DNA (≥ 1 µg at ≥ 50 ng/µL), or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRF1 gene", "Point mutations", "Small insertions/deletions", "Splice-site variants"] Parameters [{"name": "Detection Sensitivity", "reference_range": "99.9% (VAF ≥ 5%)"}, {"name": "Methodology", "reference_range": "NGS (Next-Generation Sequencing) – Full Exon Coverage"}, {"name": "Clinical Report", "reference_range": "DHA-Compliant with ACMG Variant Classification"}] Preparation ["No fasting or dietary restrictions are necessary.", "Consider a pre-test genetic counseling session."] Indications ["Diagnosis of inherited bone marrow failure syndromes", "Family screening for PRF1-related disorders", "Guiding treatment decisions for aplastic anemia"] Measurement technique Confirm with laboratory Codes LOINC: 81247-4 ICD-10: ['D61.9', 'D61.89', 'Z15.89'] Clinical summary This diagnostic test evaluates the PRF1 gene for pathogenic variants associated with inherited bone marrow failure syndromes, including aplastic anemia and FHLH2.
TEST-3100 PRKAR1A Gene Sequencing for Acrodysostosis Type 1 (With/Without Hormone Resistance) Test This test identifies pathogenic variants in the PRKAR1A gene, confirming a diagnosis of acrodysostosis type 1 and associated hormone resistance.	Peripheral Whole Blood (EDTA) or FTA Card Capillary Sample	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PRKAR1A gene sequence", "Pathogenic variants (SNVs, indels, splice site mutations)"] Parameters [] Preparation ["No fasting or special preparation required"] Indications ["Suspected acrodysostosis type 1", "Unexplained short stature with brachydactyly", "Hormone resistance (PTH, TSH, gonadotropins)"] Measurement technique Confirm with laboratory Codes LOINC: 93931-6 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the PRKAR1A gene, confirming a diagnosis of acrodysostosis type 1 and associated hormone resistance.
TEST-2949 PRKD1 Gene Analysis (Congenital Heart Defects & Ectodermal Dysplasia) Test This test evaluates the PRKD1 gene for pathogenic variants associated with congenital heart defects and ectodermal dysplasia.	Whole Blood, FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PRKD1 gene coding exons", "Flanking intronic regions"] Parameters [] Preparation ["No special preparation like fasting is needed"] Indications ["Suspected PRKD1-related disorder", "Family history of PRKD1-related disorder", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81313-2 ICD-10: Q24.9, Q82.4 Clinical summary This test evaluates the PRKD1 gene for pathogenic variants associated with congenital heart defects and ectodermal dysplasia.
TEST-4850 PRSS12 Gene Sequencing for Autosomal Recessive Intellectual Disability Type 1 (Genetic Test) This test analyzes the PRSS12 gene to detect pathogenic variants associated with autosomal recessive intellectual disability type 1 (MRT1). It uses Next-Generation Sequencing (NGS)...	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRSS12 gene", "Neurotrypsin protein coding sequence"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with clinical features suggestive of autosomal recessive intellectual disability type 1", "Family history of intellectual disability", "Carrier screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 94553-2 ICD-10: F79 Clinical summary This test analyzes the PRSS12 gene to detect pathogenic variants associated with autosomal recessive intellectual disability type 1 (MRT1). It uses Next-Generation Sequencing (NGS) for high diagnostic sensitivity.
TEST-2659 PTDSS1 Gene Lenz-Majewski Hyperostotic Dwarfism Genetic Test This test identifies pathogenic variants in the PTDSS1 gene to diagnose Lenz-Majewski hyperostotic dwarfism.	Peripheral whole blood (2–3 ml in EDTA) or dried blood spot on FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PTDSS1 gene", "Single-nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session"] Indications ["Suspected Lenz-Majewski hyperostotic dwarfism", "Pediatric patients with suggestive clinical features", "Family history suggestive of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 101842-9 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the PTDSS1 gene to diagnose Lenz-Majewski hyperostotic dwarfism.
TEST-5958 PTF1A Gene Sequencing for Pancreatic and Cerebellar Agenesis Test This test identifies pathogenic variants in the PTF1A gene associated with pancreatic and cerebellar agenesis.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (DBS)	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PTF1A gene"] Parameters [] Preparation ["Pre-test genetic counselling session", "Detailed three-generation pedigree documentation"] Indications ["Suspected pancreatic and cerebellar agenesis", "Neonatal diabetes mellitus with neurological abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 94230-1 ICD-10: Q45.0, Q04.8 Clinical summary This test identifies pathogenic variants in the PTF1A gene associated with pancreatic and cerebellar agenesis.
TEST-3756 PTH Gene Hypoparathyroidism Genetic Test This test evaluates the entire coding region of the PTH gene for pathogenic variants associated with hypoparathyroidism.	Whole Blood (Peripheral Venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PTH gene sequence", "Pathogenic variants (SNVs, Indels, CNVs)"] Parameters [] Preparation ["Fasting is not required", "Mandatory pre-test genetic counselling"] Indications ["Diagnosis of hereditary hypoparathyroidism", "Diagnosis of idiopathic hypoparathyroidism", "Predictive genetic screening for family members"] Measurement technique Confirm with laboratory Codes LOINC: 94474-6 ICD-10: E20.0, E20.8, Z13.228 Clinical summary This test evaluates the entire coding region of the PTH gene for pathogenic variants associated with hypoparathyroidism.
TEST-5598 RARS2 Gene Pontocerebellar Hypoplasia Type 6 Genetic Test This genetic test identifies pathogenic variants in the RARS2 gene associated with pontocerebellar hypoplasia type 6.	Whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RARS2 gene", "SNVs", "Indels", "Copy number variants"] Parameters [] Preparation ["Do not discontinue any prescribed medication without consulting your doctor.", "Inform the genetic counsellor about all current treatments and supplements."] Indications ["Diagnosis of pontocerebellar hypoplasia type 6", "Family counselling", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 66837-0 ICD-10: Q04.3 Clinical summary This genetic test identifies pathogenic variants in the RARS2 gene associated with pontocerebellar hypoplasia type 6.
TEST-2344 RBBP8 Gene Seckel Syndrome Type 2 Genetic Test This test detects pathogenic variants in the RBBP8 gene associated with Seckel syndrome type 2.	Whole Blood, FTA Card, Isolated DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RBBP8 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Seckel syndrome type 2", "Family history of Seckel syndrome type 2", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 86483-7 ICD-10: Q87.1, Q87.8 Clinical summary This test detects pathogenic variants in the RBBP8 gene associated with Seckel syndrome type 2.
TEST-2250 RBM10 Gene TARP Syndrome Genetic Test This test evaluates the RBM10 gene for pathogenic variants associated with TARP syndrome.	Whole Blood (EDTA) – Peripheral Venous Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RBM10 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Splice-site alterations"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling recommended"] Indications ["Suspected TARP syndrome", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This test evaluates the RBM10 gene for pathogenic variants associated with TARP syndrome.
TEST-2392 RDH11 Gene Genetic Test This test evaluates the RDH11 gene for pathogenic variants associated with inherited retinal dystrophy, juvenile cataracts, and syndromic short stature.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RDH11 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion for RDH11-related syndromic retinal dystrophy", "Family history of these features"] Measurement technique Confirm with laboratory Codes LOINC: 48000-4 ICD-10: H35.5 Clinical summary This test evaluates the RDH11 gene for pathogenic variants associated with inherited retinal dystrophy, juvenile cataracts, and syndromic short stature.
TEST-1903 RET Gene (Exons 5, 8, 10, 11, 13–16) Selective Sequencing (NGS) Test This test evaluates specific exons of the RET gene for germline mutations associated with hereditary medullary thyroid carcinoma and MEN2 syndromes.	Peripheral whole blood (3–5 mL in EDTA tube) or dried blood spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in RET gene exons 5, 8, 10, 11, 13–16", "Variant allele frequency"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomy team about recent blood transfusions or active hematological malignancy"] Indications ["Individuals with a personal or family history of medullary thyroid carcinoma (MTC)", "Individuals with a personal or family history of Multiple Endocrine Neoplasia type 2 (MEN2)", "Screening of at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 92815-9 ICD-10: Z13.89 Clinical summary This test evaluates specific exons of the RET gene for germline mutations associated with hereditary medullary thyroid carcinoma and MEN2 syndromes.
TEST-4502 RETREG1 Gene HSAN2B Genetic Test This test evaluates the RETREG1 gene for pathogenic variants associated with Hereditary Sensory and Autonomic Neuropathy Type 2B (HSAN2B). It identifies mutations causing sensory n...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RETREG1 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [{"name": "RETREG1 Gene Sequencing", "reference_range": "No pathogenic or likely pathogenic variants detected"}] Preparation ["No specific fasting required", "Continue prescribed medications unless otherwise directed by your physician"] Indications ["Individuals with clinical features suggestive of hereditary sensory and autonomic neuropathy", "Asymptomatic relatives of a confirmed HSAN2B patient", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 82159-7 ICD-10: G60.8 Clinical summary This test evaluates the RETREG1 gene for pathogenic variants associated with Hereditary Sensory and Autonomic Neuropathy Type 2B (HSAN2B). It identifies mutations causing sensory neuropathy and autonomic dysfunction.
TEST-5319 RFXANK Gene Bare Lymphocyte Syndrome Type 2 Genetic Test This test identifies pathogenic variants within the RFXANK gene associated with Bare Lymphocyte Syndrome Type 2 (BLS2).	Peripheral whole blood (EDTA), dried blood spot (FTA card), or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RFXANK gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number variations"] Parameters [] Preparation [] Indications ["Suspected Bare Lymphocyte Syndrome Type 2 (BLS2)", "Family history of primary immunodeficiency", "Recurrent severe infections"] Measurement technique Confirm with laboratory Codes LOINC: 21636-7 ICD-10: D81.7 Clinical summary This test identifies pathogenic variants within the RFXANK gene associated with Bare Lymphocyte Syndrome Type 2 (BLS2).

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.